Use the Search Fields to Find Information
Page 68 of 348
Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents
Please use this link to access this publication Abstract The purpose of this study was to evaluate if phytocannabinoids, synthetic cannabidiol (CBD), and tetrahydrocannabivarin (THCV),
January 31, 2024
Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic–Ischemic Newborn Piglets
Abstract Background: Hypoxic–ischemic (HI) insults have important deleterious consequences in newborns, including short-term morbidity with neuromotor and cognitive disturbances. Cannabidiol (CBD) has demonstrated robust neuroprotective
January 30, 2024
Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
Abstract BackgroundEpidemiological studies show a dose–response association between cannabis use and the risk of psychosis. This review aimed to determine whether there are identifiable risk-thresholds
February 29, 2024
Risk thresholds for the frequency of cannabis use during pregnancy and adverse neonatal outcomes: protocol for a systematic review and dose-response meta-analysis
Abstract Background Cannabis use during pregnancy has been increasing and is associated with adverse neonatal outcomes, such as low birth weight (LBW) and preterm birth (PTB).
December 7, 2025
Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review
Please use this link to access this publication. ABSTRACT Objectives: This paper reviews research on the topic of cannabis use and mental health harms in older
October 13, 2025
Review on clinical studies with cannabis and cannabinoids 2010-2014
In 2010 a review by Hazekamp and Grotenhermen covered controlled clinical trials of the years 2006-2009 on cannabis-based medicines, which followed the example of the
September 19, 2019
Review of the Use of Medicinal Cannabis Products in Palliative Care
Simple Summary Symptom management is a key goal of palliative cancer care. There is growing interest in the use of cannabis-based medicines or products for
December 2, 2024
Review of the neurological benefits of phytocannabinoids
Background: Numerous physical, psychological, and emotional benefits have been attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia. The
September 16, 2020
Review of the Endocannabinoid System
Please use this link to access this publication. Abstract The endocannabinoid system (ECS) is a widespread neuromodulatory network involved in the developing central nervous system
April 19, 2024
Review of cannabis use and propofol anesthesia: recent insights and clinical implications
Please use this link to access this publication. Abstract Purpose of review We examine recent evidence and clinical implications of pharmacological interactions between cannabis and
November 20, 2025
Page 68 of 348